Asthma Patient Survey study to assess asthma effect and medication in Finland

Study identifier:NIS-RFI-SYM-2006/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

INSPIRE Asthma Patient Survey to clarify the use of asthma medication and effects of asthma in everyday life in Finland

Medical condition

asthma

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

142

Study type

Observational

Age

18 Years - 70 Years

Date

Study Start Date: 01 Oct 2006

Primary Completion Date: 01 Apr 2007

Study Completion Date: 01 Apr 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2011 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1 Asthma patients using inhaled steroids as maintenance treatment	-

"There is no result for the study"

Documents available

Trial Results Summaries
Available here

Contacts

Contact

Finland Clinical Study Information

35-8102-3010

airi.puhakka@astrazeneca.com

Investigators

Principal Investigator

Airi Puhakka

AstraZeneca Finland